|CME VIDEO||Top of page|
|Learning Objectives:||Top of page|
At the completion of this educational session, participants should be able to:
- Recognize risk factors for immune reconstitution inflammatory syndrome (IRIS).
- Distinguish IRIS from other mimics.
- Understand clinical management and treatment of IRIS.
|About the Presenter:||Top of page|
Davis Boulware serves as the Associate Director of Global Health Programs in Internal Medicine at the University of Minnesota, and his research interest is in understanding the pathogenesis of HIV immune reconstitution inflammatory syndrome (IRIS). In particular, Dr. Boulware is most interested in translational research of disease pathogenesis leading to practical clinical interventions to improve outcomes. In collaboration with investigators at Makerere University and Mbarara University in Uganda, and at the University of Cape Town, in South Africa, Dr Boulware is working to improve the survival of persons with cryptococcal meningitis by identifying the optimal time to start HIV therapy after meningitis (NCT01075152). Through this trial, Dr. Boulware’s collaborative research involves characterizing the differences in immune responses that occur over time among people who develop IRIS, in an effort to identify the pathophysiology of IRIS, identify biomarkers for the prediction and diagnosis of IRIS, develop better treatments, and to prevent IRIS.
|How To Get CME||Top of page|
To obtain CME credit for this and other PRN programs, please visit the PRN Video Channel at the Clinical Education Initiative (CEI) web site http://www.ceitraining.org/prn-video/. PRN and the Medical Society of the State of New York (MSSNY) jointly sponsor PRN enduring materials for CME, and provide them at no cost to the AIDS Institute of the New York State Department of Health (NYSDOH) for broadcast through the CEI. We thank the NYSDOH for making our CME programs available to a wider audience, and hope you will also browse the many other educational opportunities offered by the CEI.